Chemoinformaics analysis of ARCTIC-ACID-B-METHYL-ESTER
| Molecular Weight | 290.365 | nRot | 3 |
| Heavy Atom Molecular Weight | 280.285 | nRig | 13 |
| Exact Molecular Weight | 290.007 | nRing | 2 |
| Solubility: LogS | -6.034 | nHRing | 2 |
| Solubility: LogP | 4.123 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 5 | APOL | 38.2539 |
| nHD | 0 | BPOL | 18.4241 |
| QED | 0.377 |
| Synth | 2.92 |
| Natural Product Likeliness | 0.864 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.463 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.235 |
| MDCK | 0.0000122 |
| BBB | 0.001 |
| PPB | 1.01605 |
| VDSS | 1.221 |
| FU | 0.0125885 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.797 |
| CYP2c19-inh | 0.944 |
| CYP2c19-sub | 0.146 |
| CYP2c9-inh | 0.934 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.624 |
| CYP2d6-sub | 0.442 |
| CYP3a4-inh | 0.887 |
| CYP3a4-sub | 0.474 |
| CL | 1.4 |
| T12 | 0.008 |
| hERG | 0.006 |
| Ames | 0.727 |
| ROA | 0.017 |
| SkinSen | 0.907 |
| Carcinogencity | 0.882 |
| EI | 0.936 |
| Respiratory | 0.111 |
| NR-Aromatase | 0.866 |
| Antiviral | Yes |
| Prediction | 0.702697 |